Skip to main content

Improving Specificity of PSA Screening: Serum and Urine Markers - Who Doesn’t Need a Prostate Biopsy?

Daniel W. Lin, MD

University of Washington

Watch Now

 

Risk Stratifying Low-risk Disease: Molecular Markers

Daniel W. Lin, MD

University of Washington

Watch Now

 

Castration-resistant Prostate Cancer: Infusion Therapeutics

Neal D. Shore, MD, FACS

Carolina Urologic Research Center
Atlantic Urology Clinics

Watch Now

 

Castration-resistant Prostate Cancer: Oral Therapeutics

Neal D. Shore, MD, FACS

Carolina Urologic Research Center
Atlantic Urology Clinics

Watch Now

 

The Role of MRI in Prostate Biopsy: Who and How to Biopsy?

Samir Taneja, MD

NYU Langone Medical Center

Watch Now

 

Treatment of Locally Advanced Prostate Cancer

Christopher J. Kane, MD

UC San Diego Health

Watch Now

 

Advances in PET Imaging

Phillip J. Koo, MD

Banner MD Anderson Cancer Center

Watch Now

 

Managing Bone Health in Advanced Prostate Cancer: What Every Urologist Should Know

Stephen Freedland, MD

Cedars-Sinai Medical Center

Watch Now

 

New Payment Models for Healthcare

Alec S. Koo, MD, FACS

Skyline Urology

Watch Now

 

Case Presentation with Panel Discussion

Herbert Lepor, MD

NYU Langone Medical Center

Watch Now

 

Advanced Prostate Cancer: Is There a Role for Urologists?

Neal D. Shore, MD, FACS

Carolina Urologic Research Center
Atlantic Urology Clinics

Watch Now

 

Future of Urology / Role of LUGPA

Neal D. Shore, MD, FACS

Carolina Urologic Research Center
Atlantic Urology Clinics

Watch Now

 

IMRT/Proton Beam/Cyberknife: Pros and Cons

Steven E. Finkelstein, MD, FACRO

Blue Ridge Cancer Care
Advanced Urology Institute

Watch Now

 

Ablation of Prostate Cancer: Is It Ready for Prime Time?

Herbert Lepor, MD

NYU Langone Medical Center

Watch Now

 

LHRH Antagonists vs Agonists

E. David Crawford, MD

University of Colorado, Anschutz Medical Campus

Watch Now